If the Pfizer-BioNTech COVID‑19 Vaccine is exported from the United States,

conditions C, D, and O through Y do not apply, but export is permitted only if 1) the

regulatory authorities of the country in which the vaccine will be used are fully

informed that this vaccine is subject to an EUA and is not approved or licensed by

FDA

https://www.fda.gov/media/150386/download

>>14437270

It's only "approved" under the EUA.

This EUA will be effective until the declaration that circumstances exist justifying the

authorization of the emergency use of drugs and biological products during the COVID-19

pandemic is terminated under Section 564(b)(2) of the Act or the EUA is revoked under Section

564(g) of the Act.